Search

Dawn T Bravo

from Berkeley, CA
Age ~66
Get Report
Also known as:
Dawn Theresa Bravo, Dawn There Bravo, Therese Dawn Bravo
Phone and address:
2322 Shattuck Ave APT 315, Berkeley, CA 94704
(510) 540-0250
Related to:
Johanna P Bravo, 49Martha Bravo, 68Juan BravoIgnacio Bravo, 73Dina P Majano, 62
Connected to:
Abraham R Bravo, 61Adrian N Bravo, 45Albino L Bravo, 94Aldo Bravo, 84Alexandro Bravo, 41Ali M Bravo, 36Amauris Bravo, 38Anais C Bravo, 42Andreina Bravo, 57Aren D Bravo, 30

Dawn Bravo Phones & Addresses

  • 2322 Shattuck Ave APT 315, Berkeley, CA 94704 (510) 540-0250
  • Santa Barbara, CA
  • Stanford, CA
  • La Jolla, CA
  • Los Angeles, CA
  • Beverly Hills, CA
  • PO Box 60343, Santa Barbara, CA 93160

Work

Position: Service Occupations

Education

Degree: High school graduate or higher

Resumes

Resumes

Dawn Bravo Photo 1

Dawn Bravo

View page
Location:
San Francisco Bay Area
Industry:
Biotechnology
Skills:
Molecular Biology
Cell Culture
Protein Purification
Protein Expression
RT-PCR
Cell Biology
Regenerative Medicine
Cancer Cell Biology
Biochemistry
Western Blotting
qPCR
Molecular Cloning
Immunoprecipitation
Cancer Research
PCR
Immunohistochemistry
Stem Cells
Flow Cytometry
Protein Chemistry
Immunofluorescence
DNA
Confocal Microscopy
ELISA
Microscopy
RNA isolation
Assay Development
Lifesciences
Cancer
SDS-PAGE
Bioinformatics
Enzyme Assays
Site-directed Mutagenesis
Scientific Writing
Biotechnology
FACS
Microbiology
Neuroscience
Agarose Gel Electrophoresis
Transfection
Fluorescence Microscopy
Tissue Culture
In Vivo
Enzyme Kinetics
Protein Engineering
Genetics
Immunology
Microarray
Biophysics
Genomics
Cell
Languages:
Japanese
Dawn Bravo Photo 2

Dawn Bravo

View page
Location:
United States

Publications

Us Patents

Methods, Compositions And Apparatuses For Detection Of Gamma-Hydroxybutyric Acid (Ghb)

View page
US Patent:
20030175846, Sep 18, 2003
Filed:
Mar 14, 2002
Appl. No.:
10/098811
Inventors:
Stanley Parsons - Santa Barbara CA, US
David Harris - Santa Barbara CA, US
Dawn Bravo - Santa Barbara CA, US
International Classification:
C12Q001/26
US Classification:
435/025000, 435/004000
Abstract:
Methods, compositions and articles of manufacture for assaying a sample for a GHB source are provided. A sample suspected of containing a GHB source is contacted with a first oxidoreductase selective for GHB and an oxidized cofactor. In the presence of GHB in the sample, the first oxidoreductase oxidizes GHB to succinic semialdehyde and reduces the cofactor. The reduced cofactor thus produced can be detected directly, or a hydride abstractor can be used that abstracts a hydride from the reduced cofactor and produces a detectable change. The hydride abstractor can be a second oxidoreductase that oxidizes the reduced cofactor and produces a detectable change in a chromogen or dye. Preferably a visual change is produced, allowing performance of the assay outside of a laboratory setting. Fusion proteins comprising the first oxidoreductase, polynucleotides encoding such proteins, host cells expressing such proteins, and vectors comprising such polynucleotides are also provided. Stabilized formulations of the first oxidoreductase are also provided. Test supports, devices, and compositions and kits comprising reagents for performing such methods are also provided. Techniques for performing the assay in the presence of ethanol and in the presence of GHB precursors in the sample are also provided.

Dominant Negative Wnt2 Compositions And Methods Of Use

View page
US Patent:
20110319337, Dec 29, 2011
Filed:
Dec 30, 2009
Appl. No.:
13/142055
Inventors:
Dawn Bravo - San Francisco CA, US
Liang You - San Francisco CA, US
Zhidong Xu - San Francisco CA, US
Biao He - South San Francisco CA, US
David M. Jablons - San Francisco CA, US
International Classification:
A61K 38/17
C12N 15/12
C12N 15/63
C12N 1/21
C07K 19/00
C12N 5/10
C12N 5/09
G01N 33/566
C12Q 1/68
A61P 35/00
C07K 14/47
C12N 1/19
US Classification:
514 193, 530395, 536 235, 4353201, 4352523, 4352542, 435325, 435366, 435348, 43525233, 435358, 435369, 435367, 435350, 435370, 435352, 435364, 435375, 435 721, 435 612, 435 723, 435 614
Abstract:
The present disclosure provides compositions, pharmaceutical preparations, kits and methods for inhibiting cell proliferation by contacting a cell expressing Fzd8 with a truncated Wnt2 polypeptide which acts as a dominant negative inhibitor of Fzd8 signaling. The present disclosure provides compositions, kits and methods for the detection of cancer by determining the level of Fzd8 and/or Wnt2 expression in a cell.
Control profile
Dawn T Bravo from Berkeley, CA, age ~66 Get Report